Intercure Ltd. Logo

Intercure Ltd.

Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.

INCR | TA

Overview

Corporate Details

ISIN(s):
IL0011063760
LEI:
549300KI5ESXF8F5GP06
Country:
Israel
Address:
11 USSISHKIN STREET, 3844346 HADERA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Intercure Ltd. is a pharmaceutical company focused on the medical cannabis sector. Its operations span research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis-based products. Operating under the brand name Canndoc, the company is recognized as a leading, profitable, and rapidly growing cannabis enterprise outside of North America. Intercure is dedicated to developing and providing high-quality, standardized cannabis products for medical use to patients and pharmacies globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 20:31
Foreign Filer Report
Immediate Report
English 322.0 KB
2025-10-08 20:31
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 473.8 KB
2025-09-19 18:49
Foreign Filer Report
Immediate Report
English 36.5 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 203.6 KB
2025-05-02 16:15
Foreign Filer Report
Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue…
English 36.2 KB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 1.9 MB
2025-05-01 16:08
Foreign Filer Report
FORM 20-F
English 36.3 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 147.7 KB
2025-02-13 09:09
Foreign Filer Report
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
English 36.3 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 120.2 KB
2025-02-04 00:14
Foreign Filer Report
Results of an Extraordinary General Meeting held on February 3, 2025
English 36.3 KB
2025-02-02 09:30
Pre-Annual General Meeting Information
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 215.3 KB
2025-02-02 09:30
Foreign Filer Report
A meeting to be held on February 3, 2025-Amendment regarding the private placem…
English 36.3 KB
2025-01-28 00:20
Foreign Filer Report
The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack…
English 121.9 KB

Automate Your Workflow. Get a real-time feed of all Intercure Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Intercure Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellid Co., Ltd. Logo
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
South Korea 299660

Talk to a Data Expert

Have a question? We'll get back to you promptly.